Home
My Highlights
Discover
Sign up
The history and mystery of sacubitril/valsartan: From clinical trial to the real world
www.frontiersin.org
patients with reduced ejection fraction heart failure who can tolerate angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
1 Users
0 Comments
6 Highlights
0 Notes
Top Highlights
patients with reduced ejection fraction heart failure who can tolerate angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
Domain
www.frontiersin.org
Ready to highlight and find good content?
Glasp is a social web highlighter that people can highlight and organize quotes and thoughts from the web, and access other like-minded people’s learning.
Start Highlighting